AVNZ

Serial Number 97405274
Registration 7154374
700

Registration Progress

Application Filed
May 11, 2022
Under Examination
Approved for Publication
Jun 20, 2023
Published for Opposition
Jun 20, 2023
Registered
Sep 5, 2023

Trademark Image

AVNZ

Basic Information

Serial Number
97405274
Registration Number
7154374
Filing Date
May 11, 2022
Registration Date
September 5, 2023
Published for Opposition
June 20, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Sep 5, 2023
Registration
Registered
Classes
005

Rights Holder

Mercury Pharma Group Limited

03
Address
Capital House
85 King William Street
London EC4N7BL
GB

Ownership History

Mercury Pharma Group Limited

Original Applicant
03
London GB

Mercury Pharma Group Limited

Owner at Publication
03
London GB

Mercury Pharma Group Limited

Original Registrant
03
London GB

Legal Representation

Attorney
Meghna Prasad

USPTO Deadlines

Next Deadline
1314 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20230905)
Due Date
September 05, 2029
Grace Period Ends
March 05, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

29 events
Date Code Type Description Documents
Sep 5, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Sep 5, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jun 20, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 20, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 31, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 15, 2023 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
May 8, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 4, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
May 4, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
May 4, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
May 4, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
May 4, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
May 4, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
May 4, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
May 4, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
May 4, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 4, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 4, 2023 ALIE A ASSIGNED TO LIE Loading...
Feb 2, 2023 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Jan 24, 2023 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Jan 24, 2023 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Jan 24, 2023 CNSL R SUSPENSION LETTER WRITTEN Loading...
Jan 24, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jan 24, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jan 24, 2023 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jan 24, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jan 18, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
May 17, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 14, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
A full line of pharmaceuticals for the treatment of depression, hypertension, malaria, metastatic prostate cancer, benign prostatic hyperplasia, partial seizures in adults with epilepsy, attention deficit hyperactivity disorder (ADHD), heart failure in adults, heart failure in pediatric patients, atrial fibrillation in adults, edema associated with congestive heart failure, edema associated with cirrhosis of the liver, edema associated with nephrotic syndrome, steroid-induced edema, idiopathic edema, edema due to secondary hyperaldosteronism, acute enterocolitis, duodenal ulcer, and irritable bowel syndrome being irritable colon, spastic colon, mucous colitis; anti-inflammatory medicines, and immunosuppressive agents, namely, corticosteroids; pharmaceutical preparations for the treatment of cancers and abnormal cells; all of the foregoing excluding pharmaceutical preparations acting on the peripheral or central nervous system, surgical kits comprised of medical and surgical apparatus and instruments, and surgical implants comprised of human and animal tissue; all of the foregoing excluding anti-infective pharmaceutical preparations

Classification

International Classes
005